Delivery Order SPE2DE24DA017-SPE2D625F9Z6M
Award Date 5/30/25
Potential Completion Date 6/4/25
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Naples, FL 34108, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a $1,817.64 delivery order from the Defense Logistics Agency's Medical Supply Chain on August 13, 2025, for an ACP MAX PRP (Autologous Conditioned Plasma Maximum Platelet-Rich Plasma) System with Autologous Conditioned Plasma technology. This fixed-price contract with economic price adjustment provisions is set to conclude by August 18, 2025, and represents a task order under Arthrex's larger Indefinite...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,029.40 on August 27, 2025, for the ACP MAX PRP System with ACDA (autologous conditioned plasma). This fixed-price delivery order with economic price adjustment is scheduled for completion by September 2, 2025, and represents performance under Arthrex's larger indefinite delivery contract with the Defense Logistics Agency's Medical Supply Chain. The order...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a $52,879.14 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, for an ACP MAX PRP System with ACDA technology. This delivery order represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) valued at $471 million and running through September 1, 2029. The contract carries no set-aside designation, reflecting Arthrex's...
- Arthrex Inc., a Naples, Florida-based manufacturer of minimally invasive orthopedic medical technologies and surgical instruments, was awarded a fixed-price delivery order valued at $22,423.50 for an ACP Max PRP System (Out of US/Europe) on December 9, 2025, with an ultimate completion date of December 12, 2025. The contract, which carries no set-aside designation, is funded through the Defense Logistics Agency's Medical Supply Chain and will be performed at Arthrex's facility in Naples,...
- The U.S. Department of Defense's Medical Supply Chain awarded a $3,960 delivery order to Arthrex Inc. on August 21, 2025, for the ACP MAX PRP System (OUS/EU). This fixed-price contract with economic price adjustment represents task order activity under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471 million and spanning June 2024 through September 2029. The delivery order is not designated as a set-aside and is scheduled for...
- Arthrex Inc. has been awarded a delivery order valued at $3,635.28 by the Defense Logistics Agency's Medical Supply Chain for an ACP MAX PRP System with ACDA functionality. The contract, issued on August 29, 2025, carries a fixed-price structure with economic price adjustment provisions and is scheduled for completion by September 4, 2025. This delivery order represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, a $471...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a $20,710.80 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain for the ACP MAX PRP System (OUS/EU). Awarded on September 5, 2025, with an ultimate completion date of September 10, 2025, this delivery order is issued under a larger indefinite delivery contract (IDC SPE2DE24D0020) valued at $471 million and running through September 1, 2029. The contract includes economic...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $17,473.50 to Arthrex Inc. for the ACP MAX PRP System (Out of US/Europe) on October 17, 2025, with an ultimate completion date of October 22, 2025. This fixed-price contract with economic price adjustment was issued without set-aside designation to the Naples, Florida-based orthopedic medical device manufacturer. The delivery order falls under Arthrex's existing single-award Indefinite Delivery Contract...
- Arthrex Inc., headquartered in Naples, Florida, was awarded a delivery order valued at $2,423.52 on January 6, 2026, for the ACP MAX PRP System with ACDA (autologous conditioned plasma maximum platelet-rich plasma system) under a fixed-price contract with economic price adjustment provisions. The contract, which has an ultimate completion date of January 9, 2026, was issued without set-aside designation and reflects Arthrex's established competitive position as a leading supplier of minimally...
- Arthrex Inc., a Naples, Florida-based manufacturer of minimally invasive orthopedic medical technologies, has been awarded a delivery order valued at $2,690.82 for the ACP MAX PRP System (OUS/EU) by the Defense Logistics Agency's Medical Supply Chain. This fixed-price delivery order with economic price adjustment is scheduled for completion by December 8, 2025, and represents work to be performed at Arthrex's Naples, Florida facility. The award carries no set-aside designation, reflecting the...